Several inherent processes have recently been identified, as follows: (1) low drug uptake and high drug efflux; (2) target mutation; (3) low tumor antigenicity; (4) surface downregulation of surface MHC; (5) dual role of interferon (IFN) signaling; and (6) regulation of oncogenic signaling. Here, HLA-C is linked to neoplasm.